New pill to fight breast cancer
A new drug is set to extend the lives of thousands of women with advanced breast cancer.
bdnews24.com News Service
bdnews24.com
Published :
03 Jun 2006, 06:00 PM
Updated :
17 Aug 2022, 06:17 PM
London, June 4 (BDNEWS) – A new drug is set to extend the lives of thousands of women with advanced breast cancer.
Doctors believe that Tykerb, made by the UK firm GlaxoSmithKline, could be even more effective than the wonder drug Herceptin because it uses a two-pronged attack on tumours.
While Herceptin has dramatically extended the lives of many patients it eventually fails to work for a substantial number.
The new drug not only targets HER2, a protein that stimulates the growth of breast cancers, it also blocks another growth factor linked to the spread of the disease, wire services reported.
The American Society of Clinical Oncology congress in Atlanta heard how Tykerb had doubled the time of survival of women with advanced breast cancer from four to eight months. It worked so well that an international study of its effects, based on 321 women, was suspended in April.
Delegates were told that women taking Tykerb were twice as likely to survive as those receiving chemotherapy.
Tykerb has already been fast-tracked in America for some types of breast cancer and should get a licence in the UK early next year.
Leading cancer specialists described it as a breakthrough.
Stephen Johnston, a specialist at the Royal Marsden hospital in London, who headed the drug's British trials, said: "The results are really exciting news."
BDNEWS/1337 hrs.